Parkinson’s News Forums Forums Parkinson’s Research Potential Parkinson’s Treatment, DNS201, Safe and Well-Tolerated in Phase 1 Study, Denali Says

  • Potential Parkinson’s Treatment, DNS201, Safe and Well-Tolerated in Phase 1 Study, Denali Says

    Posted by Forum Moderator on August 8, 2018 at 5:53 pm

    Denali Therapeutics’ reports that DNL201, an LRRK2 inhibitor, was seen to be safe in healthy people and may advance into a trial in Parkinson’s patients.

    Read more abuot this study here.

    What do you think about this news?

    replied 5 years, 10 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.